Richard Reschen is Associate Director, Business Development & Licensing within MSD’s European BD&L team since May 2020. Within the team, Richard leads Neuroscience Search & Evaluation activities in the Europe and Middle East regions for MSD. Prior to joining MSD, Richard spent 8 years at Oxford University Innovation, where he led numerous licensing and spinout projects, covering both therapeutics and medical technologies, and represented Oxford on the £13m LAB282 drug discovery initiative. Richard has an extensive network in the pharmaceutical, biotech and VC communities, and a passion for progressing the best science. Richard has a PhD in Cell Biology from the University of Cambridge.